Agenus Inc.
Agenus Inc. is dedicated to harnessing the power of the immune system to develop therapies with curative intent for individuals living with cancer. The company focuses on immuno-oncology (I-O) therapeutics, including antibody therapeutics, adoptive cell therapies, adjuvants, and vaccines, with a mission to expand the patient population benefiting from immunotherapy through innovative combination approaches.
Industries
Nr. of Employees
large (251-1000)
Agenus Inc.
Lexington, Massachusetts, United States, North America
Products
Clinical-stage antibody therapeutic programs (immuno-oncology)
A portfolio of clinical-stage monoclonal antibody programs focused on immuno-oncology indications, including combination regimens evaluated in colorectal and ovarian cancers.
Adoptive cell therapy and vaccine/adjuvant programs
R&D-stage adoptive cell therapy programs and vaccine/adjuvant platforms developed via subsidiary operations or dedicated internal units.
Clinical-stage antibody therapeutic programs (immuno-oncology)
A portfolio of clinical-stage monoclonal antibody programs focused on immuno-oncology indications, including combination regimens evaluated in colorectal and ovarian cancers.
Adoptive cell therapy and vaccine/adjuvant programs
R&D-stage adoptive cell therapy programs and vaccine/adjuvant platforms developed via subsidiary operations or dedicated internal units.
Services
Medical information and investigator support
Provision of medical information, contact request handling, and support for investigator-sponsored clinical trials and access to investigational medicines.
Manufacturing asset transfer and technology transfer services
Transfer of manufacturing assets and technology transfer activities to partner organizations to support biologics supply and scale-up.
Partnership and licensing collaborations
Structuring of strategic collaborations, licensing arrangements and co-development partnerships to accelerate program development and provide commercial optionality.
Medical information and investigator support
Provision of medical information, contact request handling, and support for investigator-sponsored clinical trials and access to investigational medicines.
Manufacturing asset transfer and technology transfer services
Transfer of manufacturing assets and technology transfer activities to partner organizations to support biologics supply and scale-up.
Partnership and licensing collaborations
Structuring of strategic collaborations, licensing arrangements and co-development partnerships to accelerate program development and provide commercial optionality.
Expertise Areas
- Immuno-oncology antibody therapeutics
- Antibody Fc engineering
- Clinical trial management and execution
- Neoadjuvant oncology development
Key Technologies
- Monoclonal antibody engineering
- Fc-region (effector) engineering
- CTLA-4 targeted immunotherapy
- Combination immunotherapy regimens